Drug Search Results
More Filters [+]

Desogestrel

Alternative Names: desogestrel, cerazette, desogen, kalliga, pimtrea, volnea, kariva, bekyree, isibloom, mircette, simliya, enskyce, viorele, emoquette, cyclessa, kimidess, ortho-cept, velivet, azurette, cyred eq, juleber, apri 28 day, reclipsen 28 day, caziant triphasic regimen, velivet triphasic regimen
Latest Update: 2025-01-11
Latest Update Note: Clinical Trial Update

Product Description

Desogestrel and ethinyl estradiol combination is used to prevent pregnancy. It is a birth control pill that contains two types of hormones, desogestrel and ethinyl estradiol, and when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization (pregnancy) is prevented. (Sourced from: https://www.mayoclinic.org/drugs-supplements/desogestrel-and-ethinyl-estradiol-oral-route/side-effects/drg-20061362?p=1)

Mechanisms of Action: ER Agonist,PR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Teva
Company Location: PETACH TIKVA L3 49131
Company CEO: Kåre Schultz
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Desogestrel

Countries in Clinic: France, Japan

Active Clinical Trial Count: 3

Highest Development Phases

Phase 3: Infertility

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

jRCT2031230276

P3

Recruiting

Unknown

2025-05-31

DSO-024-23

P1

Not yet recruiting

Healthy Volunteers

2024-09-05

RANDOS

P3

Completed

Infertility

2023-10-30

Recent News Events